Context Therapeutics
(NASDAQ) CNTX
Context Therapeutics Financials at a Glance
Market Cap
$238.89M
Revenue (TTM)
$0.00
Net Income (TTM)
$40.23M
EPS (TTM)
$-0.43
P/E Ratio
-6.08
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$2.62
Volume
1,916,361
Open
$2.45
Price
$2.62
Volume
1,916,361
Open
$2.45
Previous Close
$2.60
Daily Range
$2.44 - $2.62
52-Week Range
$0.49 - $3.62
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$2.62
Volume
1,916,361
Open
$2.45
Previous Close
$2.60
Daily Range
$2.44 - $2.62
52-Week Range
$0.49 - $3.62
CNTX News
CNTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Context Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
15
CEO
Martin A. Lehr, MA
Website
www.contexttherapeutics.comHeadquarters
Philadelphia, PA 19103, US
CNTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-56%
Return on Capital
-83%
Return on Assets
-68%
Earnings Yield
-16.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$238.89M
Shares Outstanding
91.88M
Volume
1.92M
Avg. Volume
855.66K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$39.70M
EBITDA
$39.69M
Operating Cash Flow
$26.39M
Capital Expenditure
$33.95K
Free Cash Flow
$26.42M
Cash & ST Invst.
$66.00M
Total Debt
$112.06K
Context Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$36.10K
N/A
Gross Margin
0.00%
N/A
Market Cap
$238.89M
N/A
Market Cap/Employee
$19.91M
N/A
Employees
12
N/A
Net Income
$8.68M
-89.6%
EBITDA
$9.34M
-69.1%
Quarterly Fundamentals
Net Cash
$54.25M
-39.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$122.37K
+48.1%
Short Term Debt
$160.06K
+44.1%
Return on Assets
-68.34%
N/A
Return on Invested Capital
-83.17%
N/A
Free Cash Flow
$11.47M
-126.5%
Operating Cash Flow
$11.43M
-127.3%